We hypothesized that (I) ADAMTS-13 activity differs according to stroke etiology, (II) ADAMTS-13 activity is inversely associated with the number of vascular risk factors, and (III) lower ADAMTS-13 activity may reflect a higher probability for paradoxical embolism in stroke patients with PFO. The gene discussed is ADAMTS13; the disease is stroke disorder.